Free Trial

Precision Optics (POCI) Competitors

Precision Optics logo
$4.23 -0.01 (-0.24%)
Closing price 10/14/2025 04:00 PM Eastern
Extended Trading
$4.24 +0.00 (+0.12%)
As of 10/14/2025 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

POCI vs. INO, HYPR, PDEX, APYX, OBIO, NSPR, FONR, NTRB, ZJYL, and PSTV

Should you be buying Precision Optics stock or one of its competitors? The main competitors of Precision Optics include Inovio Pharmaceuticals (INO), Hyperfine (HYPR), Pro-Dex (PDEX), Apyx Medical (APYX), Orchestra BioMed (OBIO), InspireMD (NSPR), Fonar (FONR), Nutriband (NTRB), Jin Medical International (ZJYL), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry.

Precision Optics vs. Its Competitors

Precision Optics (NASDAQ:POCI) and Inovio Pharmaceuticals (NASDAQ:INO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations, valuation and media sentiment.

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 26.8% of Inovio Pharmaceuticals shares are owned by institutional investors. 16.3% of Precision Optics shares are owned by insiders. Comparatively, 2.3% of Inovio Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Precision Optics has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500. Comparatively, Inovio Pharmaceuticals has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500.

Precision Optics has higher revenue and earnings than Inovio Pharmaceuticals. Precision Optics is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.09M1.71-$5.78M-$0.84-5.04
Inovio Pharmaceuticals$182.34K711.15-$107.25M-$2.61-0.93

In the previous week, Inovio Pharmaceuticals had 1 more articles in the media than Precision Optics. MarketBeat recorded 3 mentions for Inovio Pharmaceuticals and 2 mentions for Precision Optics. Precision Optics' average media sentiment score of 0.95 beat Inovio Pharmaceuticals' score of 0.91 indicating that Precision Optics is being referred to more favorably in the media.

Company Overall Sentiment
Precision Optics Positive
Inovio Pharmaceuticals Positive

Inovio Pharmaceuticals has a net margin of 0.00% compared to Precision Optics' net margin of -30.28%. Precision Optics' return on equity of -51.33% beat Inovio Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-30.28% -51.33% -31.18%
Inovio Pharmaceuticals N/A -163.32%-96.41%

Inovio Pharmaceuticals has a consensus price target of $8.80, indicating a potential upside of 260.66%. Given Inovio Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Inovio Pharmaceuticals is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Inovio Pharmaceuticals
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29

Summary

Inovio Pharmaceuticals beats Precision Optics on 9 of the 16 factors compared between the two stocks.

Get Precision Optics News Delivered to You Automatically

Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POCI vs. The Competition

MetricPrecision OpticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$32.71M$7.00B$6.04B$10.50B
Dividend YieldN/A1.18%5.73%4.80%
P/E Ratio-5.0426.7984.6427.24
Price / Sales1.7127.55508.12197.88
Price / CashN/A21.5837.5761.53
Price / Book2.645.1812.256.74
Net Income-$5.78M$178.09M$3.32B$276.59M
7 Day Performance-2.76%-2.86%-1.34%-0.47%
1 Month Performance-3.64%5.12%8.14%7.47%
1 Year Performance1.20%5.21%72.27%34.58%

Precision Optics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POCI
Precision Optics
0.9153 of 5 stars
$4.23
-0.2%
N/A-0.5%$32.71M$19.09M-5.0480
INO
Inovio Pharmaceuticals
3.8076 of 5 stars
$2.39
-0.8%
$8.80
+268.2%
-57.2%$128.07M$220K-0.92320Gap Down
HYPR
Hyperfine
1.078 of 5 stars
$1.72
+13.2%
$1.28
-25.4%
+106.2%$119.44M$12.89M-3.31190High Trading Volume
PDEX
Pro-Dex
3.0554 of 5 stars
$32.82
-3.0%
$56.00
+70.6%
-9.4%$110.39M$66.59M12.16140News Coverage
APYX
Apyx Medical
1.6788 of 5 stars
$2.84
-1.7%
N/A+193.1%$109.30M$48.10M-6.31270Gap Down
High Trading Volume
OBIO
Orchestra BioMed
3.1795 of 5 stars
$2.73
-1.4%
$13.50
+394.5%
-31.1%$107.04M$2.64M-1.494
NSPR
InspireMD
2.9072 of 5 stars
$2.42
-3.2%
$4.50
+86.0%
-10.2%$100.97M$7.07M-3.2350
FONR
Fonar
1.5698 of 5 stars
$15.89
-0.7%
N/A+3.1%$99.25M$104.35M12.92480News Coverage
Analyst Forecast
NTRB
Nutriband
2.2358 of 5 stars
$7.84
flat
$13.00
+65.8%
-5.7%$94.35M$2.14M-2.7310Gap Down
ZJYL
Jin Medical International
N/A$0.50
-11.9%
N/A-85.0%$88.87M$23.50M0.00245High Trading Volume
PSTV
Plus Therapeutics
3.768 of 5 stars
$0.82
-7.7%
$8.00
+874.3%
-46.7%$88.30M$5.82M-0.3720Gap Down

Related Companies and Tools


This page (NASDAQ:POCI) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners